Sign in
8-K

Current Report

NEKTAR THERAPEUTICS Filed Acc 0001213900-22-036694

Executive or director change

  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading ea162348-8k_nektar.htm…